May 22, 2017 / 6:45 AM / 3 months ago

BRIEF-Vectura says to present positive phase I data for VR942

May 22 (Reuters) - Vectura Group Plc:

* Vectura group plc - vr942 positive phase i data to be presented at American Thoracic Society 113th Annual Conference

* VR942 was well tolerated by healthy volunteers and mild asthmatics in phase i with no difference in safety profile compared to placebo

* Based on phase I data, Vectura and UCB finalising preparation for phase ii clinical study, which is expected to commence in h2 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 80 6749 1136)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below